Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.
Singer CF; ABCSG; Holst F, Steurer S, Burandt EC, Lax SF, Jakesz R, Rudas M, Stöger H, Greil R; ABCSG; Sauter G, Filipits M; ABCSG; Simon R, Gnant M; ABCSG. Singer CF, et al. Among authors: holst f. Clin Cancer Res. 2022 Sep 15;28(18):4112-4120. doi: 10.1158/1078-0432.CCR-21-4328. Clin Cancer Res. 2022. PMID: 35920686 Free PMC article. Clinical Trial.
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.
Burandt E, Jens G, Holst F, Jänicke F, Müller V, Quaas A, Choschzick M, Wilczak W, Terracciano L, Simon R, Sauter G, Lebeau A. Burandt E, et al. Among authors: holst f. Breast Cancer Res Treat. 2013 Feb;137(3):745-53. doi: 10.1007/s10549-013-2406-4. Epub 2013 Jan 16. Breast Cancer Res Treat. 2013. PMID: 23322234
Estrogen receptor gene amplification occurs rarely in ovarian cancer.
Issa RM, Lebeau A, Grob T, Holst F, Moch H, Terracciano L, Choschzick M, Sauter G, Simon R. Issa RM, et al. Among authors: holst f. Mod Pathol. 2009 Feb;22(2):191-6. doi: 10.1038/modpathol.2008.130. Epub 2008 Aug 8. Mod Pathol. 2009. PMID: 18690166 Free article.
On the evidence for ESR1 amplification in breast cancer.
Holst F, Moelans CB, Filipits M, Singer CF, Simon R, van Diest PJ. Holst F, et al. Nat Rev Cancer. 2012 Jan 24;12(2):149. doi: 10.1038/nrc3093-c3. Nat Rev Cancer. 2012. PMID: 22270954 No abstract available.
Role of cyclin D1 amplification and expression in vulvar carcinomas.
Choschzick M, Hess S, Tennstedt P, Holst F, Bohlken H, Gieseking F, Mahner S, Woelber L, Simon R, Sauter G. Choschzick M, et al. Among authors: holst f. Hum Pathol. 2012 Sep;43(9):1386-93. doi: 10.1016/j.humpath.2011.11.014. Epub 2012 Mar 9. Hum Pathol. 2012. PMID: 22406359
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
Holst F, Werner HMJ, Mjøs S, Hoivik EA, Kusonmano K, Wik E, Berg A, Birkeland E, Gibson WJ, Halle MK, Trovik J, Cherniack AD, Kalland KH, Mills GB, Singer CF, Krakstad C, Beroukhim R, Salvesen HB. Holst F, et al. Clin Cancer Res. 2019 Jan 1;25(1):334-345. doi: 10.1158/1078-0432.CCR-18-0452. Epub 2018 Nov 15. Clin Cancer Res. 2019. PMID: 30442683 Free PMC article.
44 results